Improved Cash GenerationA strong 2025 operating cash flow and positive free cash flow materially improve near-term liquidity and reduce reliance on external financing. Durable cash generation supports servicing debt, funding working capital and targeted investments, increasing the firm's flexibility over coming quarters.
Infrastructure Revenue And Backlog StrengthLarge, growing Infrastructure revenue and a $1.7B+ backlog provide multi-quarter revenue visibility and support operational planning. Backlog reduces near-term demand uncertainty, underpins cash conversion in construction projects, and strengthens the structural foundation of the Infrastructure business.
Regulatory Wins For MediBeaconEU CE Mark complements existing US/China approvals and expands clinical/research access to the TGFR system. Regulatory validation fosters durable adoption, supports commercialization in Europe, and increases long-term value and diversification from INNOVATE's life-sciences investments.